{"doi":"10.21203/rs.3.rs-19693/v2","title":"Genetic deletion of microRNA-22 blunts the inflammatory transcriptional response to status epilepticus and exacerbates epilepsy in mice","abstract":"<title>Abstract</title>\n        <p>MicroRNAs perform important roles in the post-transcriptional regulation of gene expression. Sequencing as well as functional studies using antisense oligonucleotides, indicate important roles for microRNAs during the development of epilepsy through targeting transcripts involved in neuronal structure, gliosis and inflammation. MicroRNA-22 (miR-22) has been reported to protect against the development of epileptogenic brain networks through suppression of neuroinflammatory signalling. Here, we used mice with a genetic deletion of miR-22 to extend these insights. Mice lacking miR-22 displayed normal behaviour and brain structure and developed similar status epilepticus after intraamygdala kainic acid compared to wildtype animals. Continuous EEG monitoring after status epilepticus revealed an accelerated and exacerbated epilepsy phenotype whereby spontaneous seizures began sooner, occurred more frequently and were of longer duration in miR-22-deficient mice. RNA sequencing analysis of the hippocampus during the period of epileptogenesis revealed a specific suppression of inflammatory signalling in the hippocampus of miR-22-deficient mice. Taken together, these findings indicate a role for miR-22 in establishing early inflammatory responses to status epilepticus. Inflammatory signalling may serve anti-epileptogenic functions and cautions the timing of anti-inflammatory interventions for the treatment of status epilepticus.</p>","journal":"Research Square","year":null,"id":39427,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":193648,"name":"Cristina R Reschke","orcid":null,"position":1,"is_corresponding":false},{"id":193649,"name":"Ngoc T Nguyen","orcid":null,"position":2,"is_corresponding":false},{"id":193650,"name":"Elena Langa","orcid":null,"position":3,"is_corresponding":false},{"id":193651,"name":"Amaya Sanz Rodriguez","orcid":null,"position":4,"is_corresponding":false},{"id":193652,"name":"Fernanda R. Temp","orcid":null,"position":5,"is_corresponding":false},{"id":193653,"name":"Mayara L. Freitas","orcid":null,"position":6,"is_corresponding":false},{"id":193654,"name":"Rogerio R Gerbatin","orcid":null,"position":7,"is_corresponding":false},{"id":193655,"name":"Ronan M Conroy","orcid":null,"position":8,"is_corresponding":false},{"id":193656,"name":"Gary P Brennan","orcid":null,"position":9,"is_corresponding":false},{"id":193639,"name":"Tobias Engel","orcid":null,"position":10,"is_corresponding":false},{"id":65585,"name":"David C. Henshall","orcid":"0000-0001-6237-9632","position":11,"is_corresponding":false},{"id":193647,"name":"Luiz FA Silva","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"41953230","pmcid":null,"openalex_id":"https://openalex.org/W4251222761","authors":[],"funders":[{"funder_name":"European Commission","grant_id":"602130","title":"MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy"},{"funder_name":"Science Foundation Ireland","grant_id":"17/CDA/4708","title":"The ATP-gated purinergic P2X7 receptor as a novel target for the treatment of drug-refractory epilepsy"},{"funder_name":"Science Foundation Ireland","grant_id":"13/IA/1891","title":"MicroRNA biofluid profiles as molecular diagnostics for epilepsy"},{"funder_name":"Science Foundation Ireland","grant_id":"16/RC/3948","title":"FutureNeuro"},{"funder_name":"Science Foundation Ireland","grant_id":"17/TIDA/5002","title":"MicroRNA-22 as a novel disease-modifying treatment for epilepsy"}],"total_grants":5,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"green","license":"cc-by","oa_locations":[{"url":"https://www.researchsquare.com/article/rs-19693/v2.pdf?c=1631848975000","host_type":"repository"},{"url":"https://www.researchsquare.com/article/rs-19693/v2.pdf?c=1631848975000","host_type":"repository"},{"url":"https://www.researchsquare.com/article/rs-19693/v2","host_type":"publisher"},{"url":"https://www.researchsquare.com/article/rs-19693/v2.html","host_type":"publisher"},{"url":"https://doi.org/10.21203/rs.3.rs-19693/v2","host_type":"repository"},{"url":"https://doi.org/10.21203/rs.3.rs-19693/v3","host_type":""},{"url":"https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-020-00653-x","host_type":""},{"url":"https://doi.org/10.21203/rs.3.rs-19693/v1","host_type":""},{"url":"https://doi.org/10.1186/s13041-020-00653-x","host_type":""},{"url":"https://pubmed.ncbi.nlm.nih.gov/32825833","host_type":""},{"url":"http://dx.doi.org/10.1186/s13041-020-00653-x","host_type":""},{"url":"https://doaj.org/article/437cebdae0ed4f06ac210951c4c7a083","host_type":""},{"url":"https://dx.doi.org/10.1186/s13041-020-00653-x","host_type":""},{"url":"https://zenodo.org/records/3996836","host_type":""},{"url":"https://discovery-pp.ucl.ac.uk/id/eprint/10109761/","host_type":""}],"fields_of_study":["MicroRNA in disease regulation","Circular RNAs in diseases","RNA regulation and disease"],"mesh_terms":[],"keywords":["Status epilepticus","Epilepsy","microRNA","Neuroscience","Medicine","Cancer research","Biology","Bioinformatics","Gene","Genetics","Inflammation","Male","Transcription, Genetic","Research","Antagomirs","Down-Regulation","Hippocampus","Mice","MicroRNAs","Phenotype","Oligonucleotide","Disease Progression","Animals","Female","Neurology. Diseases of the nervous system","Temporal lobe epilepsy","RC346-429","kainic acid","Gene Deletion","Signal Transduction","closure","fetal","myelomeningocele","myofascial","surgery"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-11T20:04:06.264663Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}